The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurgical Innovations Share News (SUN)

Share Price Information for Surgical Innovations (SUN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.50
Bid: 0.40
Ask: 0.60
Change: 0.00 (0.00%)
Spread: 0.20 (50.00%)
Open: 0.50
High: 0.50
Low: 0.50
Prev. Close: 0.50
SUN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Friday broker round-up UPDATE

Fri, 17th Jan 2014 10:05

Aberdeen Asset Management: JP Morgan cuts target price from 544p to 529p, while its overweight rating remains unchanged. Canaccord Genuity reduces target price from 586p to 540p and reiterates a buy recommendation. UBS lowers target price from 540p to 520p and keeps a buy recommendation.Ashtead Group: JP Morgan increases target price from 817p to 913p and stays with its overweight rating.Associated British Foods: Societe Generale raises target price from 2260p to 2600p and reiterates a hold recommendation.AstraZeneca: UBS increases target price from 400p to 4150p and keeps its buy recommendation.Aviva: Goldman Sachs takes target price from 230p to 260p and reiterates a neutral rating.Bovis Homes Group: HSBC increases target price from 1065p to 1125p keeping an overweight rating.Brain Juicer: Canaccord Genuity takes target price from 298p to 350p retaining its buy recommendation.Croda International: UBS moves target price from 2500p to 2525p maintaining its neutral rating.CSR: Liberum Capital raises target price from 580p to 700p, while downgrading to hold.Diageo: JP Morgan reduces target price from 2050p to 1970p downgrading to neutral.Dixons Retail: Investec lowers target price from 62p to 56p keeping its buy recommendation. UBS shapes target price from 60p to 58p leaving its buy recommendation unchanged.Domino Printing: UBS increases target price from 720p to 840p reiterating a neutral rating.Experian: Canaccord Genuity reduces target price from 905p to 858p retaining its sell recommendation.F&C Asset Management: Canaccord Genuity cuts target price from 130p to 110p and downgrades from buy to hold.First Group: Panmure Gordon ups target price from 120p to 140p and reiterates its hold recommendation.Halfords Group: Citi shifts target price from 545p to 550p and stays with its buy recommendation.Harvey Nash: Panmure Gordon moves target price from 126p to 135p retaining a buy recommendation.Hays: Liberum Capital starts with a target price of 170p and a buy recommendation.Home Retail: Deutsche Bank shifts target price from 225p to 230p maintaining a buy recommendation. Societe Generale ups target price from 158p to 175p, while still recommending selling. Citi moves target price from 195p to 205p and retains a neutral rating. HSBC ups target price from 220p to 250p and reiterates its overweight rating. Nomura moves target price from 215p to 230p and maintains a buy recommendation.Inchcape: Panmure Gordon raises target price from 675p to 750p and reiterates a buy recommendation.Informa: Westhouse Securities shifts target price from 570p to 580p and leaves its neutral rating unaltered.Intertek Group: Credit Suisse reduces target price from 3500p to 3200p downgrading to neutral.Jupiter Fund Management: Espirito Santo raises target price from 429p to 465p and leaves its buy recommendation unchanged.Legal & General Group: Goldman Sachs moves target price from 205p to 215p and maintains a neutral rating.Morrison (Wm: Societe Generale starts with a target price of 200p and a sell recommendation.Michael Page: Liberum Capital initiates with a target price of 575p and a buy recommendation.Optos: Panmure Gordon takes target price from 206p to 235p keeping a buy recommendation.Petrofac: Nomura raises target price from 1300p to 1430p upgrading to buy.Premier Oil: Deutsche Bank cuts target price from 520p to 500p and retains a buy recommendation. Societe Generale reduces target price from 385p to 320p downgrading to hold. Liberum Capital ups target price from 300p to 320p and keeps a hold recommendation. UBS cuts target price from 400p to 350p retaining a buy recommendation.Prudential: Goldman Sachs ups target price from 1500p to 1580p and keeps a strong buy recommendation.Renew Holdings: WH Ireland takes target price from 190p to 235p and reiterates its buy recommendation.Resolution: Goldman Sachs shifts target price from 335p to 340p and maintains a neutral rating.Rio Tinto: JP Morgan raises target price from 4400p to 4500p leaving its overweight rating unchanged. UBS moves target price from 4040p to 4050p and keeps a buy recommendation.Robert Walters: Liberum Capital starts with a target price of 415p and a buy recommendation.Royal Bank of Scotland: Investec moves target price from 335p to 345p, while downgrading to sell.Sainsbury: Societe Generale initiates with a target price of 370p and a hold recommendation.Smith (DS): Berenberg starts with a target price of 400p and a buy recommendation.Standard Life: Goldman Sachs ups target price from 320p to 335, but still keeps a sell recommendation.SThree: Liberum Capital initiates with a target price of 475p and a buy recommendation.St James's Place: Goldman Sachs increases target price from 770p to 810p and retains a buy recommendation. JP Morgan raises target price from 724p to 811p leaving its overweight rating unaltered.Surgical Innovations: Panmure Gordon downgrades from buy to hold with a target price of 5p.Synergy Health: Investec reduces target price from 1650p to 1400p leaving its buy recommendation unaltered.Synthomer: UBS ups target price from 255p to 280p, while downgrading from buy to neutral.Tesco: Societe Generale cuts target price from 290p to 270p keeping its sell recommendation.Tribal Group: Canaccord Genuity ups target price from 221p to 240p and stays with its buy recommendation. WH Ireland takes target price from 235p to 260p retaining a buy recommendation.Tullow Oil: Liberum Capital reduces target price from 1445p to 1367p, while its buy recommendation remains unchanged.Unilever: Panmure Gordon reduces target price from 2525p to 2280p retaining its hold recommendation.
More News
15 Apr 2014 08:38

Surgical Innovations Profit Hit By Investment, Exchange Rate

LONDON (Alliance News) - Surgical Innovations Group PLC Tuesday posted a decline in pretax profit for 2013, despite seeing revenue rise, due to the US Dollar exchange rate and its investment in streamlining its manufacturing operations. Surgical Innovations produces devices for use in minim

Read more
15 Apr 2014 07:50

UK MORNING BRIEFING: Aggreko Leads After Mixed Results

LONDON (Alliance News) - Aggreko is leading the FTSE 100 in early trading Tuesday after the temporary power company said it has seen mixed results in its first quarter, with strong underlying revenue growth in two of its three regions being impacted by adverse currency movements as previously exp

Read more
6 Feb 2014 14:02

Sector movers: Mobile telecoms, healthcare stocks rise as results impress

The mobile telecoms and healthcare categories were putting in decent performances on Thursday in London after results from sector heavyweights Vodafone and Smith & Nephew impressed. Vodafone gained 2.4% in afternoon trade after revenues declined by a less-than-expected 3.6% in the third quarter to

Read more
17 Jan 2014 11:31

Surgical Innovations profits hit by invest plan and exchange rates

Shares in Surgical Innovations declined sharply after the company warned its profits had been hit by the US dollar exchange rate and its investment during the second half. The company, which develops solutions for minimally invasive surgery, said it therefore expected 2013 earnings before interest

Read more
17 Jan 2014 10:15

UK BROKER RATING CHANGES: Goldman Raises View On Insurance Sector

LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning:
----------
FTSE 100
----------
SOCGEN STARTS MORRISON WITH 'SELL' - TARGET 200 PENCE
----------
SOCGEN CUTS PRICE TARGET TESCO TO 270 (290) PENCE -

Read more
17 Jan 2014 08:28

Surgical Innovations Shares Drop On Profit Warning

LONDON (Alliance News) - Shares in Surgical Innovations Group PLC fell sharply Friday morning after it said that its adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) for the full year ended December 31 would be significantly below the previous year. The company

Read more
17 Jan 2014 08:13

UK MORNING BRIEFING: Shares Open Higher Despite Shell Warning

LONDON (Alliance News) - UK shares have opened higher Friday despite negative news from two FTSE 100 companies, Royal Dutch Shell and Shire.

The oil major issued a profit warning, and the pharmaceutical firm said it will book a loss on the sale of

Read more
5 Nov 2013 10:28

Surgical Innovations Ships First Products Under Surgioscopy Deal

Read more
24 Oct 2013 10:29

Surgical Innovations To Develop New Production Facility In Leeds

Read more
4 Oct 2013 10:28

Surgical Innovations Appoints Romain Pizzi To Clinical Advisory Board

Read more
10 Sep 2013 10:23

Surgical Innovations Group Profits Jump As Sales Increase 28%

Read more
10 Sep 2013 09:15

Surgical Innovations adds progress in US to strong UK H1

Keyhole surgery equipment specialist Surgical Innovations sold more of its own branded products in the first half, leading to a strong rise in profits. The AIM-listed company, which flagged up these results in a pre-close statement, revealed its efforts to push into the US had resulted in an expan

Read more
10 Sep 2013 08:17

Tuesday broker round-up UPDATE

African Barrick Gold: Investec shifts target price from 135p to 137p, while downgrading from hold to sell. Aquarius Platinum: JP Morgan moves target price from 39p to 49p, while downgrading from neutral to underweight. Citi lowers target price from 66p to 54p and downgrades from buy to neutral. As

Read more
16 Aug 2013 08:44

Surgical Innovations triples profits in first half

First half profits have more than tripled at keyhole surgery equipment maker Surgical Innovations as many UK hospitals convert to using its products. The AIM company said revenues for the six months to end-June were 28% ahead of the same period last year at £3.88m, with profit before tax for the p

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.